Skip to main content

Table 3 Life support therapies and outcomes

From: Impact on antimicrobial consumption of procalcitonin-guided antibiotic therapy for pneumonia/pneumonitis associated with aspiration in comatose mechanically ventilated patients: a multicenter, randomized controlled study

 

PCT group (n = 81)

Control group (n = 78)

p

Adjusted p*

SOFA Score

 Day 2

4.3 ± 3.0

3.6 ± 3.3

0.26

0.94

 Day 3

4.3 ± 2.6

4.1 ± 3.4

0.72

0.93

 Day 5

3.9 ± 2.9

4.4 ± 2.7

0.57

0.84

 Day 7

3.8 ± 2.9

3.1 ± 2.8

0.46

0.69

No. of days on mechanical ventilation

3.7 ± 3.6

2.7 ± 2.5

0.03

0.07

Catecholamines

28 (35)

18 (23)

0.11

0.31

Renal replacement therapy

3 (4)

0

0.25

0.95

Length of ICU stay (days)

6.4 ± 6.5

4.6 ± 3.5

0.04

0.06

Death in ICU

5 (6.1)

4 (5.1)

0.78

0.80

Death in-hospital (after ICU discharge)

3 (3.7)

4 (5.1)

0.72

0.38

Death at 28 days

5 (6.2)

9 (11.5)

0.27

0.20

Death at 90 days

8 (9.9)

9 (12.8)

0.73

0.42

  1. SOFA Sequential Organ Failure Assessment, ICU intensive care unit
  2. *Adjusted for SAPS II score